Webinar: «Calprotectin, a new routine inflammation biomarker»

03. Feb 2022 | 3 min read

Webinar: «Calprotectin, a new routine inflammation biomarker»

Webinar with Dr Camille Chenevier-Gobeaux from Assistance publique - Hôpitaux de Paris

This webinar was sent live 8th February 2022. You can watch the recording here. 

Calprotectin is a novel inflammation biomarker with diagnostic value in various infectious and inflammatory conditions. Calprotectin for plasma and serum is gaining more interest and is today also in routine use at various hospitals and laboratories across Europe. Speaker Dr Camille Chenevier-Gobeaux from Assistance publique - Hôpitaux de Paris, will in this webinar highlight the distinctive clinical value of calprotectin whilst sharing her experience from implementing the marker into clinical routine at the APHP hospitals.

This webinar is especially noteworthy for laboratory professionals and clinicians who are already familiar with plasma and serum calprotectin, and that are curious to learn more from the experience of routine customers of the Gentian Calprotectin GCAL®.

 

New call-to-action

 

If you want to learn more about the biomarker calprotectin and the Gentian GCAL® assay please find more information on our product page and detailed articles.

 

Contact us for further information

Explore GCAL® in your laboratory - fill out the form or send an email to marketing@gentian.com for more information about the product and prices.

 

 

You may also read


GCAL® Customer Interview: Calprotectin in routine care across departments

Mar 30, 2026

GCAL® Customer Interview: Calprotectin in routine care across departments

From laboratory integration to clinical impact at Motol University Hospital Inflammation is rarely..

GCAL® Customer Story - 24/7 calprotectin testing in acute and chronic care

Mar 27, 2026

GCAL® Customer Story - 24/7 calprotectin testing in acute and chronic care

Enabling 24/7 circulating calprotectin testing in clinical practice

Calprotectin as a biomarker for immune dysfunction and 28‑day mortality in sepsis

Mar 26, 2026

Calprotectin as a biomarker for immune dysfunction and 28‑day mortality in sepsis

Circulating calprotectin: biomarker of immune dysfunction in sepsis - study results Results from a post-hoc..